RTX Corporation vs Novartis AG
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
RTX Corporation
$257.8B
์์ #55
Novartis AG
$272.5B
์์ #51
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- RTX Corporation์ด(๊ฐ) 2025๋ ๊น์ง Novartis AG์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Novartis AG์ด(๊ฐ) 2026๋ ๊น์ง RTX Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | RTX Corporation | Novartis AG | ์ ๋ |
|---|---|---|---|
| 2026 | $257.8B | $272.5B | Novartis AG |
| 2025 | $245.1B | $227.3B | RTX Corporation |
| 2024 | $151.8B | $177.6B | Novartis AG |
| 2023 | $107.9B | $163.8B | Novartis AG |
| 2022 | $126.1B | $146.3B | Novartis AG |
| 2021 | $105.1B | $134.5B | Novartis AG |
| 2020 | $85.2B | $134.7B | Novartis AG |
| 2019 | $109.2B | $142.4B | Novartis AG |
| 2018 | $75.9B | $110.8B | Novartis AG |
| 2017 | $89.0B | $104.0B | Novartis AG |
| 2016 | $74.7B | $89.6B | Novartis AG |
| 2015 | $63.8B | $100.4B | Novartis AG |
| 2014 | $74.5B | $103.4B | Novartis AG |
| 2013 | $72.2B | $76.6B | Novartis AG |
| 2012 | $50.9B | $59.2B | Novartis AG |
| 2011 | $44.2B | $52.5B | Novartis AG |
| 2010 | $46.5B | $51.1B | Novartis AG |
| 2009 | $40.0B | $50.7B | Novartis AG |
| 2008 | $30.1B | $44.5B | Novartis AG |
| 2007 | $42.0B | $50.6B | Novartis AG |
| 2006 | $33.8B | $55.9B | Novartis AG |
| 2005 | $29.7B | $53.9B | Novartis AG |
| 2004 | $27.0B | $43.8B | Novartis AG |
| 2003 | $24.4B | $42.0B | Novartis AG |
| 2002 | $15.7B | $36.9B | Novartis AG |
| 2001 | $16.1B | $43.1B | Novartis AG |
| 2000 | $19.4B | $50.7B | Novartis AG |
| 1999 | $15.8B | $40.7B | Novartis AG |
| 1998 | $13.1B | $46.3B | Novartis AG |
| 1997 | $8.6B | $40.1B | Novartis AG |
| 1996 | $7.7B | $24.5B | Novartis AG |
| 1995 | $5.4B | $16.9B | Novartis AG |